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Human immunodeficiency virus type 1 (HIV-1) contains two copies of genomic RNA that are noncovalently
linked via a palindrome sequence within the dimer initiation site (DIS) stem-loop. In contrast to the current
paradigm that the DIS stem or stem-loop is critical for HIV-1 infectivity, which arose from studies using T-cell
lines, we demonstrate here that HIV-1 mutants with deletions in the DIS stem-loop are replication competent
in peripheral blood mononuclear cells (PBMCs). The DIS mutants contained either the wild-type (5GCGC
GC3) or an arbitrary (5ACGCGT3) palindrome sequence in place of the 39-nucleotide DIS stem-loop
(NLCGCGCG and NLACGCGT). These DIS mutants were replication defective in SupT1 cells, concurring with the
current model in which DIS mutants are replication defective in T-cell lines. All of the HIV-1 DIS mutants were
replication competent in PBMCs over a 40-day infection period and had retained their respective DIS
mutations at 40 days postinfection. Although the stability of the virion RNA dimer was not affected by our DIS
mutations, the RNA dimers exhibited a diffuse migration profile when compared to the wild type. No defect in
protein processing of the Gag and GagProPol precursor proteins was found in the DIS mutants. Our data
provide direct evidence that the DIS stem-loop is dispensable for viral replication in PBMCs and that the
requirement of the DIS stem-loop in HIV-1 replication is cell type dependent.
All retroviruses, including human immunodeficiency virus
type 1 (HIV-1), contain two copies of virion genomic RNA (for
a review, see references 6, 27, and 38). These virion dimeric
RNAs are noncovalently linked at the 5 end of the RNA
genome and undergo rearrangement to form more-stable
RNA dimers during the maturation of virion proteins (11, 12,
35, 45).
The packaging of the HIV-1 RNA genome is mediated by
the four stem-loop structures found near the 5 end of the
RNA genome (6). These stem-loop structures are also referred
to as the dimer initiation site (DIS) stem-loop, splice donor
(SD) stem-loop, packaging () stem-loop, and Gag initiation
stem-loop (1). A highly conserved palindrome sequence (5G
CGCGC3, also known as the DIS and the kissing-loop) within
the DIS stem-loop is important for the formation of viral RNA
dimers in vitro (20, 44). Other variants of palindrome DIS-loop
sequences (5GTGCAC3) and (5TGCGCA3) have also
been found in a minor proportion of HIV-1 subtypes (46). The
fact that the DIS stem-loop forms part of the HIV-1 genomic
RNA packaging sequence may, in part, explain the strong
correlation between genomic RNA dimerization and virion
RNA packaging during HIV-1 assembly (1).
The formation of a dimeric RNA genome in infectious ret-
roviruses can be roughly divided into three different steps.
These are (i) the initiation of genomic RNA dimer formation,
(ii) the conformational rearrangement of the dimeric RNA
(11, 12, 35, 36, 41, 45), and (iii) the stabilization of genomic
RNA dimers (11, 12, 35, 36, 45). Steps ii and iii are often
collectively referred to as the maturation of RNA dimers,
which coincides with the proteolytic cleavage of Gag and Gag-
ProPol (11, 12, 35, 36, 45). The proteolytic processing of the
primary cleavage site (p2/nucleocapsid [NC]) is particularly
important for the stabilization of the dimeric virion RNA ge-
nomes (42). Overexpression of a protease (PR)-negative Gag-
ProPol in the virion-producing cells generates noninfectious
HIV-1 that contains mainly monomeric RNA genomes (40,
43).
While the processing of the primary cleavage site in HIV-1
Gag is important for the stabilization of the virion RNA ge-
nome (42), proteolytic processing of virion proteins in HIV-1
Gag only particles is not sufficient to generate dimeric RNA
with wild-type (wt) conformation (41). These data suggest that
both reverse transcriptase (RT) and integrase (IN) are also
important for the formation of wt RNA dimers and that the
virion dimeric RNAs assume a number of different conforma-
tions throughout the process of virion assembly (41). These
variable forms of dimeric RNAs found in HIV-1 are reminis-
cent of the wt mature, PR-negative immature, and wt rapid-
harvest (slow migrating) dimeric RNAs found in the Moloney
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murine leukemia virus system (12) and the different types of
RNA dimers found in in vitro RNA dimerization systems (21,
22).
Although virion RNA packaging is not critical for the pro-
duction and release of retroviral particles (10, 14, 15, 31–33), it
is generally held that virion RNA dimer formation occurs prior
to the packaging of genomic RNA (7, 47). While the DIS
stem-loop is critical for the dimerization of virion RNA in vitro
(20, 44), mutations within this region have variable effects on
the dimerization of genomic RNA in the virion (4, 8, 16, 23,
37). It is unclear which RNA sequence drives the initiation of
genomic RNA dimerization in the virion. The role of the DIS
stem-loop in HIV-1 replication in T-cell lines, such as SupT1
(4, 37), C8166 (16), and MT4 (23, 24, 26), as well as non-T-cell
reporter cell lines, such as HOS cells, has been extensively
evaluated (8). It is now commonly accepted that the DIS stem-
loop structure or the DIS loop is vital for HIV-1 replication
(48). In general, these DIS mutants are also defective in RNA
packaging (4, 8, 23, 37), and it is thought that the defects of
viral replication in these mutants are associated with their
defects in genomic RNA packaging and/or dimerization. In
addition, it has been shown that the DIS is also important in
mediating the complete synthesis of viral cDNA in infected
cells (37). However, the replication of HIV-1 DIS stem-loop
mutants in primary cells, such as peripheral blood mononu-
clear cells (PBMCs), has never been examined.
In this study, we provide direct evidence that the DIS stem-
loop is dispensable for HIV-1 replication in PBMCs but re-
mains critical for viral replication in SupT1 cells. Deletions of
the DIS stem altered the mobility but did not affect the stability
of virion RNA dimers. No defect in the processing of HIV-1
Gag and GagProPol precursor proteins was found in these DIS
mutant virions. The level of the genomic RNA packaged by the
DIS mutant particles was approximately 50% that of the wild
type. In addition, the DIS mutants were found to have an
increased level of 4-kb singly spliced HIV-1 RNA when com-
pared to the wild type. Our data on virion RNA packaging and
dimerization are in agreement with previous reports (4, 8, 16,
23, 37), demonstrating that the DIS stem-loop is important for
virion RNA packaging but is not essential for virion RNA
dimer formation. We further show that the packaging of wt
levels of virion RNA and the DIS stem-loop were not critical
for HIV-1 replication in PBMCs.
MATERIALS AND METHODS
Construction of plasmid DNAs. The wt HIV-1 proviral DNA NL4.3 was
obtained from the NIH AIDS Reagents Program. The numbering of RNA
sequences in Fig. 1 is based on the RNA genome of NL4.3. A 39-nucleotide (nt)
sequence encompassing the DIS stem-loop (HIV-1 RNA residues 242 to 280)
within the NL4.3 proviral DNA was replaced with the 10-nt palindrome sequence
(5ACGCGCGCGT3) to generate NLGCGCGC that has the wt DIS sequence
(Fig. 1). Similarly, NLACGCGT was constructed by replacing the same 39-nt
sequence (HIV-1 RNA residues 242 to 280) within the NL4.3 proviral DNA with
an arbitrarily chosen 6-nt palindrome sequence (5ACGCGT3) to generate
NLACGCGT (Fig. 1). Both mutants were constructed via site-directed PCR mu-
tagenesis using specific PCR primers as previously described (17, 18, 40–42).
DNA sequencing was performed to confirm the presence of the desired muta-
tions and the absence of spontaneous mutations via PCR mutagenesis.
Virus production. Mutant and wt HIV-1 were produced by transfection of
proviral DNA into 293T cells as previously described (30). Viral particles were
FIG. 1. Schematic representation of the DIS stem-loop sequences in the HIV-1 RNA genome. The numerical values are based on the RNA
nucleotide position of NL4.3. The deletion sequences are indicated as dotted lines. The italic font highlights the DIS sequences or the palindrome
sequences within the stem-loop. This figure is modified from a figure in the study by Berkhout (1).
FIG. 2. Replication kinetics of wt HIV-1 and DIS stem-loop mutants in PHA-stimulated PBMCs (A) and T-cell line Sup T1 (B). PHA-
stimulated freshly isolated PBMCs or SupT1 cells were infected with either NL4.3 wt (■) or mutant (NLGCGCGC [] and NLACGCGT []) viruses.
Supernatants were collected 3, 7, 10, and 14 days after infection, and RT activity in each sample was measured. Results represent means and
standard deviations of triplicate samples and are representative of eight and six sets of experiments for PBMCs and Sup T1, respectively.
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isolated 36 h posttransfection. Briefly, supernatants were centrifuged for 30 min
at 2,000 g, 4°C (Beckman) to remove cellular debris. The clarified supernatants
were either frozen at 70°C or used immediately for further analysis. Cells were
washed twice with 1 Tris-buffered saline (TBS) (50 mM Tris [pH 7.4], 150 mM
NaCl) followed by protein extraction using lysis buffer containing 1 TBS, 10 l
of Nonidet P-40 per ml, 20 mM phenylmethylsulfonyl fluoride, 1 M pepstatin,
and 1 M leupeptin.
Infectivity assay. PBMCs were isolated from buffy packs (supplied by the Red
Cross Blood Bank, Melbourne) as described previously (9). PBMCs were then
stimulated with phytohemagglutinin (PHA) (10 g/ml; Murex Diagnostics) for 3
days and cultured in RPMI 1640 medium containing 10% fetal calf serum
(RF10) and 10 units of interleukin-2 (Boehringer-Mannheim) per ml. SupT1
cells (kindly provided by Dale McPhee, The Burnet Institute, Australia) were
cultured in RF10. Infectivity was tested on virus stocks obtained from either
transfection or long-term infection of PBMCs (see below). Sample virus stocks
with equivalent levels of RT activity, as determined by a micro-RT assay (13),
were mixed with 105 PBMCs or SupT1 cells in a 96-well tissue culture plate.
Eight 10-fold serial dilutions of each virus were tested in triplicate. Supernatants
were collected on days 3, 7, 10, and 14 postinfection and subsequently stored at
70°C. Viral infectivity was measured by monitoring the production of viral RT
activity by using a micro-RT assay (13). The infectivities of wt and mutant viral
particles were quantified by using a 50% tissue culture infective dose (TCID50)
method as previously described (9).
Measurement of virion RNA packaging and virion RNA dimer formation.
Pelleted wt and mutant virions derived from transfected 293T cells were nor-
malized according to p24 levels (HIV-1 p24 antigen immunoassay; Abbott Lab-
oratories). Virion RNAs were extracted as previously described (11, 12). Virion
RNAs were electrophoretically separated on a denatured agarose gel to examine
the impact of DIS mutations on virion RNA packaging (40). A dilution series of
wt virion RNA was used to construct a standard curve to quantify the amount of
genomic RNA being packaged into the mutant HIV-1 for the equivalent levels of
virion-associated p24.
The stability and the conformation of virion RNA dimers isolated from wt and
DIS mutant HIV-1 derived from both transfected 293T cells and infected
PBMCs were assessed. PHA-stimulated PBMCs (2  107) were infected with wt
and DIS mutant HIV-1 for 10 days as described below. Virion RNA was isolated,
and a native RNA dimerization gel assay was utilized as previously described (11,
12). Briefly, dimeric RNAs were heated at 4, 25, 37, 42, 48, and 52°C for 10 min
in an RNA dimerization buffer (10 mM Tris [pH 7.5], 1 mM EDTA, 25 mM
NaCl), immediately followed by a quick chill on ice. The dimeric and monomeric
RNAs were then separated by electrophoresis (18, 40–43). The electrophoreti-
cally separated RNAs were then transferred onto nitrocellulose (Amersham) as
previously described (18, 40–43). The virion RNA on the nitrocellulose was
detected by use of a 150-nt in vitro-synthesized radioactive riboprobe
(pGEM7zHIV-1), which is complementary to the R-U5 regions of the HIV-1
genomic RNA (NL4.3 RNA sequences nt 77 to 227) (18, 40–43).
Intracellular viral protein analysis. Cell lysates were rapidly freeze-thawed
three times to weaken the cellular membrane. Cell debris was subsequently removed
by centrifugation for 30 min at 4°C, 20,000  g. The transfection efficiency of the
samples was determined by measuring the level of enhanced green fluorescent
protein from the reporter plasmid by use of a Bio Imaging Analyser (Fuji Photo Film
Co.). Cellular protein from each sample, normalized for equivalent levels of en-
hanced green fluorescent protein, was mixed with 3 l of sample buffer (100 mM
Tris [pH 6.8], 3% sodium dodecyl sulfate [SDS], 33% glycerol, and 0.03% bromo-
phenol blue), denatured for 10 min at 95°C, and resolved by SDS–10% polyacryl-
amide gel electrophoresis (PAGE). Resolved proteins were transferred to a nitro-
cellulose membrane (Amersham). The membrane was blocked for 2 h in 3% casein
dissolved in 1TBS containing 0.3% Tween 20 (TBST) and probed overnight at 4°C
with pooled HIV-1 seropositive patient sera. After three washes with 1 TBST
buffer, the membrane was incubated with anti-human horseradish peroxidase-con-
jugated secondary antibody (DAKO) for 2 h at room temperature. An enhanced
chemiluminescence technique (Amersham) was used for visualization of HIV-1
proteins present in the cellular lysates.
Virion purification and protein analysis. Supernatants from transfected cells
were purified and concentrated by ultracentrifugation through a 20% sucrose
cushion by using a Beckman ultracentrifuge L-90 model (SW 41 rotor) at 100,000
 g for 1 h at 4°C. Pellets were resuspended in 50 l of TBS lysis buffer. Equal
amounts of virion protein (as determined by virion-associated p24) from each
sample were mixed with 3 l of sample buffer containing 5 mM -mercapto-
ethanol, heated for 10 min at 95°C. Virion proteins were then resolved by
SDS–10% PAGE as described above. The resolved virion protein samples were
transferred onto nitrocellulose membranes by electrophoresis using a Bio-Rad
transfer apparatus. Virion HIV-1 protein profiles of the samples were deter-
mined by Western analysis as described above.
Long-term culture and sequencing analysis of the viral genome in the infected
PBMCs. PHA-stimulated PBMCs were infected with wt and DIS mutant HIV-1
derived from transfected 293T cells. Virus stocks were treated with DNase to
prevent contamination of plasmid DNA prior to the initial infection. PBMCs
infected with wt and mutant HIV-1 were maintained in culture for 10 days.
Cell-free culture fluids were then collected, and RT activities were compared.
Cell pellets were collected and stored at 70°C for DNA sequencing. Collection
of culture fluids and cell pellets at day 10 of infection marked the end of the first
passage of wt and mutant HIV-1 in primary cells. A total of four passages in
PBMCs were performed in parallel for wt and DIS mutant HIV-1. Equivalent
amounts of viruses (as determined by the levels of RT activity) were used as input
viruses in each of the four passages of PBMC infection. Similar levels of RT
activities were detected in the culture fluids collected from wt and DIS mutant
HIV-1-infected PBMCs within each passage. The resultant viral supernatants
from each passage were tested for infectivity in SupT1 cells as described above.
DNA was extracted from infected PBMCs by incubating cell pellets with 1DNA
extraction buffer (20 mM Tris-HCl [pH 8.0], 50 mM KCl, 0.45% NP-40, 0.45%
Tween 20, and 60g of proteinase K/ml) at 37°C for 16 h. Heating at 95°C for 10 min
subsequently inactivated the proteinase K in the samples. Viral DNA fragments
containing nt 37 to 517, nt 947 to 1197, and nt 1387 to 1627 (numbering corresponds
to the RNA sequences) were amplified via specific PCR primers pairs containing
ApaI and EcoRI sequences. The three sets of primers were DIS/MA sense (5CCC
GAA TTC CTG AGC CTG GGA GCT CTC TGG C3) and DIS/MA antisense
(5CCC GGG CCC ACG CGT CTA GCT CCC TGC TTG CCC3) (set 1); CA
sense (5CCC GAA TTC GAG ACC ATC AAT GAG GAA GCT GCA GAA
TGG GAT3) and CA antisense (5CCC GGG CCC ACG CGT TTT GGT CCT
TGT CTT ATG TCC AGA ATG C3) (set 2); and p2/NC sense (5CCC GAA TTC
AGG GAG TGG GGG GAC CCG GCC ATA AAG3) and p2/NC antisense
(5CCC GGG CCC ACG CGT AGC CTG TCT CTC AGT ACA ATC TTT C3)
(set 3). The DIS stem-loop region and the selected matrix (MA), capsid (CA), p2
and NC coding sequences were monitored because compensatory mutations have
been found in these regions after long-term culturing of partial DIS stem-loop
deleted mutants in MT4 cells (25, 26). PCR products were digested with the restric-
tion enzymes ApaI and EcoRI and cloned into the pGEM7z vector for DNA
sequencing. Sequencing was performed with an automating fluorescence DNA se-
quencer (Applied Biosystems) at the Baker Institute, Melbourne, Australia. For
each passage of a given wt or mutant virus, four to five separate clones were
sequenced with each primer set.
TABLE 1. Virion infectivitya of wt and DIS mutant HIV-1
Cells
TCID50 (103 cpm) of RT activity in experiment no.:
1 2 3 4 5 6 7 8
PBMCs
NL4.3 150,000 3,200 560,000 320,000 320 560 320,000 56,000
NLACGCGT 320,000 560 32,000 180,000 180 56 32,000 5,600
NLGCGCGC 5,600 56 32,000 320,000 32 56 460,000 32,000
SupT1
NL4.3 32,000 3,200 3,200 1,800 180,000 320,000
NLACGCGT 3.2 0.56 0.56 3.2 3.2 0.32
NLGCGCGC 3.2 3.2 0.56 3.2 5.6 0.56
a TCID50 was measured as described in Materials and Methods. cpm, counts per minute.
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RESULTS AND DISCUSSION
The DIS stem-loop is not required for HIV-1 replication in
PHA-stimulated PBMCs. Previous work has shown that the
DIS stem-loop is critical for HIV-1 replication in T-cell lines
(4, 8, 16, 23, 37), but the role of DIS in HIV-1 replication in
PBMCs has not been examined. Two DIS mutants
(NLGCGCGC and NLACGCGT) were used in this study.
NLGCGCGC has the natural palindrome DIS sequence (5GC
GCGC3) in place of the 39-nt DIS stem-loop in NL4.3.
NLACGCGT has an arbitrary palindrome sequence, 5ACGCG
T3, in place of the 39-nt DIS stem-loop in NL4.3 (Fig. 1).
Mutant and wt HIV-1 were generated by transfecting the in-
dicated proviral DNAs into 293T cells. Parallel infections were
carried out by using the T-cell line SupT1 and PHA-stimulated
PBMCs. Mutant and wt HIV-1 collected from the supernatant
of the transfected 293T cells were normalized for RT activity
prior to infection. Equivalent amounts of wt and DIS mutant
virions were used to infect both PBMCs and SupT1 cells. The
replication kinetics and TCID50 of wt and DIS mutants were
determined through infections with PBMCs from eight differ-
ent donors and six independent SupT1 infections.
The HIV-1 DIS mutants were replication defective in SupT1
cells (Fig. 2B), which is consistent with reported data from
assays using T-cell lines (37). However, NLGCGCGC and
NLACGCGT were replication competent in PBMCs (Fig. 2A).
The TCID50 of each virus was measured to assess the relative
infectivity among wt (NL4.3) and the DIS mutants in both
PBMCs and Sup T1 cells (Table 1). Our data show that for
equivalent levels of RT activity the HIV-1 DIS mutants were
consistently replication competent in PBMCs from eight do-
nors (Table 1). In contrast, the parallel infection study in
SupT1 cells showed that the same NLGCGCGC and NLACGCGT
virus stocks were approximately 1,000 to 10,000 times less
infectious than the wt HIV-1 (Table 1).
The DIS stem-loop is important for virion RNA packaging
and the formation of discrete RNA dimers. Cell-free in vitro
RNA binding studies have shown that the DIS loop sequence
(Fig. 1, RNA nt 257 to 262) is critical for viral RNA dimeriza-
FIG. 3. (A) Mutations in DIS stem-loop inhibit virion packaging of genomic RNA. Virion particles were produced by transfecting the indicated
proviral DNA into 293T cells. Virion RNA samples that were normalized via a quantitative p24 assay were separated by electrophoresis on a
denatured agarose gel. A dilution series of wt virion RNA was used to construct a standard curve. The impact of mutations on virion RNA
packaging was visualized by Northern analysis and quantified by phosphorimaging. Results are representative of three sets of experiments. (B) The
conformation but not the stability of HIV-1 virion RNA dimers from transfected 293T cells was affected by mutations of the DIS stem-loop. Virion
RNA dimers were isolated from transfected 293T cells and prepared as described in Materials and Methods. Viral monomeric and dimeric RNA
species were separated on a 1% native agarose gel via electrophoresis after the samples were heated for 10 min at various temperatures (4, 25,
37, 42, 48, and 52°C, lanes 1 to 6, respectively). Viral RNAs were visualized by Northern analysis using a radioactive riboprobe that specifically
recognizes HIV-1 RNA. Results are representative of five sets of experiments.
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tion (20, 44). Previous reports have shown that deletions sim-
ilar to those used in this study (NLGCGCGC and NLACGCGT)
reduce the packaging of virion RNA and/or impair the forma-
tion of discrete RNA dimers (4, 8, 16, 23, 37). Genomic RNA
packaging and dimerization analyses were carried out with our
DIS mutants to verify the demonstrated impact of DIS muta-
tions on virion RNA genomes. The virion packaging of
genomic RNA in these DIS mutants was reduced to approxi-
mately 50% of that of the wt normalized for the same amount
of p24 proteins (Fig. 3A). While the amount of virion genomic
RNA packaged for both of the DIS mutants was reduced, there
was an increased level of 4-kb viral RNA compared to that of
the wild type (Fig. 3A). One possibility for this phenomenon is
that RNA packaging-deficient virus-like particles may nonspe-
cifically incorporate excess singly spliced viral RNA and/or
cellular RNA to compensate for the reduction of genomic
RNA packaging during retroviral assembly (28, 34). These data
also highlighted that reduction of genomic RNA packaging by
50% compared to the wt was sufficient for the replication of
HIV-1 DIS mutants in primary cells.
RNA dimerization analysis of wt and DIS mutant RNA
derived from transfected 293T cells demonstrated that while
the formation of discrete RNA dimers was impaired in each of
the DIS mutants, the stability of the virion RNA dimers, as
determined by the first appearance of the monomeric RNA
band after heating at 42°C, was not affected (Fig. 3B). In-
creased levels of spliced mRNA are visible in each of the DIS
mutants compared to the levels observed with the wt when
heated to 48 or 52°C, which is consistent with the increased
level of 4-kb viral RNA observed for the DIS mutants in the
RNA packaging analysis using a denaturing RNA gel. These
results suggest that the diffuse RNA dimer may, at least in part,
be a consequence of the spliced RNA that is packaged within
the DIS mutant virions. To determine whether the conforma-
tion of the DIS mutant RNA dimers was rescued following
successful infection of PBMCs, RNA dimerization analysis was
carried out with virion RNA isolated after wt and DIS mutants
had been used to infect PBMCs for 10 days (Fig. 4). Again, the
formation of discrete RNA dimers was impaired in each of the
DIS mutants while the stability of the virion RNA dimers was
not altered. The finding that the conformation but not the
stability of the RNA dimers was affected by DIS mutations is in
agreement with the hypothesis that other non-DIS stem-loop
RNA sequences are involved in the process of HIV-1 RNA
dimer formation (1, 4), and retroviral RNA dimerization may
rely on multiple segments of the retroviral RNA genomes (29,
36, 39).
Mutations in the HIV-1 DIS stem-loop structure do not
alter the processing of viral proteins or yield compensatory
mutations in p2 and NC sequences in the viral genome of the
HIV-1-infected PBMCs. It has been reported that the DIS
deletion is associated with defects in precursor protein pro-
cessing and this processing defect can be rescued by compen-
satory mutations in p2 and NC sequences (25). Furthermore,
compensatory mutations in the matrix and capsid can also
rescue the defects of viral infectivity in DIS deletion mutants
(26). Western blot analysis of intracellular viral protein (Fig. 5)
and pelleted virion proteins from 293T cells transfected with
the various DIS mutants showed that the virion protein profiles
were similar to those of wt virus (Fig. 5), suggesting that our
DIS mutations did not influence the processing of viral pro-
teins.
DNA sequencing was performed for wt- and DIS mutant
(NLGCGCGC and NLACGCGT)-infected PBMC cultures 40 days
postinfection in three discrete experiments. Four to five clones
were sequenced for each sample, and in all cases the sequences
of the clones were identical. Previous studies have reported
that compensatory mutations are required to rescue the infec-
tivity of DIS-deleted HIV-1 mutants in T cells (25, 26); no such
mutation was found in the corresponding MA, CA, p2, and NC
sequences in the viral genome of NLGCGCGC- and NLACGCGT-
infected primary cells. The respective DIS deletions were
maintained in the NLGCGCGC- and NLACGCGT-infected
PBMC cultures 40 days postinfection (data not shown). DNA
sequencing (as described in Materials and Methods) revealed
no changes to the DNA sequence when compared to the input
viruses. To rule out the possibility of contamination with a
replication-competent virus in the NLGCGCGC- and
NLACGCGT-infected PBMC cultures, replication kinetics were
determined for SupT1 cells by using supernatant collected
FIG. 4. The conformation but not the stability of HIV-1 virion
RNA dimers isolated from PBMCs was affected by mutations of the
DIS stem-loop. Virion RNA dimers were isolated from infected
PBMCs and prepared as described in Materials and Methods. Viral
monomeric and dimeric RNA species were separated on a 1% native
agarose gel by electrophoresis after the samples had been heated for
10 min at various temperatures (4, 25, 37, 42, 48, and 52°C, lanes 1 to
6, respectively). Viral RNAs were visualized by Northern analysis with
a radioactive riboprobe that specifically recognizes HIV-1 RNA. Re-
sults are representative of three sets of experiments.
FIG. 5. Mutations in the HIV-1 DIS stem-loop do not alter the
intracellular viral protein and virion protein profile. Intracellular
(293T cells) and virion proteins were resolved by SDS–10% PAGE.
The viral proteins were visualized by Western blotting using pooled
HIV-1-positive patient sera and anti-human horseradish peroxidase-
conjugated secondary antibody. Results are representative of five sets
of experiments.
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from each passage of two sets of the long-term infections (eight
in total). Although replication competent in PBMCs, viruses
present in the supernatants of NLGCGCGC- and NLACGCGT-
infected PBMC cultures were replication defective in SupT1
cells (Fig. 6), which indicates that there was no contamination.
These results correspond with the DNA sequencing data show-
ing that the sequences of the NLGCGCGC and NLACGCGT input
viruses were unaltered after 40 days in PBMCs. Consequently,
our data show that there is no strong selective pressure for a wt
DIS stem-loop sequence to support HIV-1 replication in PB-
MCs.
In this study, we have demonstrated that the requirement of
the HIV-1 DIS stem-loop in virus replication is cell type de-
pendent. The finding that the DIS deletion mutants cannot
replicate in SupT1 cells while the DIS is largely dispensable for
replication in PBMCs suggests the involvement of a DIS-de-
pendent cellular factor. Our data also demonstrate that wt
levels of genomic RNA packaging are not critical for HIV-1
replication in primary cells.
Paillart et al. (37) have shown that the DIS stem-loop is
important for the synthesis of cDNA during reverse transcrip-
tion in the T-cell line SupT1. The cell type-dependent effects of
DIS deletions on HIV-1 replication suggest that this DIS-
dependent cellular factor may directly or indirectly bind to the
DIS stem-loop to enhance HIV-1 replication, perhaps by as-
sisting in the synthesis of cDNA at the early stage of the HIV-1
replication cycle. However, since the DIS stem-loop is part of
the complex RNA structure in the 5 untranslated region,
which is important at multiple stages of HIV-1 replication, the
impact of DIS mutations on other aspects of HIV-1 replica-
tion, such as RNA splicing and the regulation of protein trans-
lation, should also be considered.
Using an in vitro system, Berkhout et al. (3, 5) and Huthoff
and Berkhout (19) have shown that the HIV-1 5 leader RNA
sequences assume different conformations at various stages of
viral replication. It has been suggested that the conformation
of the 5 leader RNA may play a part in regulating viral
replication (2). Fu et al. have previously shown that the HIV-1
dimeric virion RNA genome assumes two distinct conforma-
tions before and after virion particle maturation (11). Distinct
conformations of RNA dimers can also be found in other
retroviruses (12, 35, 36, 45). We have recently shown that in
addition to these two conformations of RNA dimers, HIV-1
virion RNA can assume a number of different dimeric confor-
mations depending on the presence or the absence of HIV-1
PR, RT, and IN (41). These data support the notion that the
reverse-transcription and dimerization reactions may be cou-
pled through conformational changes within the leader RNA
(2). Our data also support the suggestion that in addition to the
ascribed roles of genomic RNA packaging and the formation
of discrete RNA dimers, the DIS stem-loop is also involved in
other aspects of HIV-1 replication.
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